GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi Ve (IST:ANGEN) » Definitions » EBIT

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve (IST:ANGEN) EBIT : ₺144.9 Mil (TTM As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve EBIT?

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2023 was ₺15.6 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2023 was ₺144.9 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's annualized ROC % for the quarter that ended in Sep. 2023 was -2.26%. Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was 16.08%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was 6.31%.


Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve EBIT Historical Data

The historical data trend for Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve EBIT Chart

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
EBIT
1.79 8.81 362.05 464.33 341.72

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve Quarterly Data
Dec18 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.92 22.53 14.09 92.71 15.57

Competitive Comparison of Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's EBIT

For the Medical Devices subindustry, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's EV-to-EBIT falls into.



Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺144.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve  (IST:ANGEN) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's annualized ROC % for the quarter that ended in Sep. 2023 is calculated as:

ROC % (Q: Sep. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2023 ) + Invested Capital (Q: Sep. 2023 ))/ count )
=-44.276 * ( 1 - 75.56% )/( (453.116 + 503.745)/ 2 )
=-10.8210544/478.4305
=-2.26 %

where

Invested Capital(Q: Jun. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=850.318 - 12.113 - ( 385.089 - max(0, 29.708 - 590.221+385.089))
=453.116

Invested Capital(Q: Sep. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=890.541 - 23.212 - ( 363.584 - max(0, 45.223 - 599.627+363.584))
=503.745

Note: The Operating Income data used here is four times the quarterly (Sep. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2023  Q: Sep. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=62.26/( ( (202.106 + max(171.627, 0)) + (214.13 + max(186.695, 0)) )/ 2 )
=62.26/( ( 373.733 + 400.825 )/ 2 )
=62.26/387.279
=16.08 %

where Working Capital is:

Working Capital(Q: Jun. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(68.943 + 96.1 + 33.867) - (12.113 + 0 + 15.17)
=171.627

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(68.197 + 121.803 + 39.253) - (23.212 + 0 + 19.346)
=186.695

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2023 )
=144.892/2295.748
=6.31 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve EBIT Related Terms

Thank you for viewing the detailed overview of Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve (IST:ANGEN) Business Description

Traded in Other Exchanges
N/A
Address
Egitim Mah. Kasap Ismail, Sk. No:10 D:23, Kadikoy, Istanbul, TUR, 34722
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi Ve Ticaret AS is an international biotechnology company. It is engaged in designing, developing, and manufacturing Real-Time PCR kits, nucleic acid extraction kits, and automated nucleic acid extraction instruments. It also manufactures NA Extraction kits, Microbiology kits, Genetic Disorders kits, Panel kits, Sequencing kits, Food Testing kits.

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve (IST:ANGEN) Headlines

No Headlines